Published in Neuropsychology on January 01, 2016
Neuregulin signaling pathway in smoking behavior. Transl Psychiatry (2017) 0.75
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods (2007) 50.83
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature (2009) 33.26
The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry (1992) 21.60
Biological insights from 108 schizophrenia-associated genetic loci. Nature (2014) 16.13
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature (2012) 14.76
Systematic localization of common disease-associated variation in regulatory DNA. Science (2012) 14.47
Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet (2009) 12.96
Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet (2003) 11.63
Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet (2011) 7.80
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
De novo mutations in schizophrenia implicate synaptic networks. Nature (2014) 6.59
A polygenic burden of rare disruptive mutations in schizophrenia. Nature (2014) 5.99
The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J Intern Med (2002) 5.37
GeneCards 2002: towards a complete, object-oriented, human gene compendium. Bioinformatics (2002) 4.24
Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell (2013) 3.26
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry (1998) 2.39
Endophenotypes in the genetic analyses of mental disorders. Annu Rev Clin Psychol (2006) 2.35
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. Am J Hum Genet (2000) 2.07
Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples. Arch Gen Psychiatry (2007) 2.04
Converging genetic and functional brain imaging evidence links neuronal excitability to working memory, psychiatric disease, and brain activity. Neuron (2014) 1.70
Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res (2011) 1.62
Adjudicating neurocognitive endophenotypes for schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2007) 1.48
Enhanced neurocognitive functioning and positive temperament in twins discordant for bipolar disorder. Am J Psychiatry (2014) 1.48
The global cognitive impairment in schizophrenia: consistent over decades and around the world. Schizophr Res (2013) 1.38
SZGR: a comprehensive schizophrenia gene resource. Mol Psychiatry (2010) 1.36
Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT). Mol Psychiatry (2013) 1.34
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2013) 1.30
Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer? Mol Psychiatry (2008) 1.30
Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. PLoS One (2012) 1.27
Quantitative genetic modeling of regional brain volumes and cognitive performance in older male twins. Biol Psychol (2002) 1.27
White matter integrity in individuals at high genetic risk of bipolar disorder. Biol Psychiatry (2011) 1.23
Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance. Biol Psychiatry (2010) 1.16
Genetics of human episodic memory: dealing with complexity. Trends Cogn Sci (2011) 1.13
Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biol Psychiatry (2013) 1.06
The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 1.04
Frontal white matter integrity as an endophenotype for schizophrenia: diffusion tensor imaging in monozygotic twins and patients' nonpsychotic relatives. Front Hum Neurosci (2009) 1.03
Cumulative genetic risk and prefrontal activity in patients with schizophrenia. Schizophr Bull (2012) 1.02
Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry (2013) 1.00
Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: potential role for IL-17 pathway. Schizophr Res (2013) 0.99
Genetic architecture of learning and delayed recall: a twin study of episodic memory. Neuropsychology (2011) 0.98
Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res (2011) 0.97
GWAS for executive function and processing speed suggests involvement of the CADM2 gene. Mol Psychiatry (2015) 0.93
Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia. Genome Med (2012) 0.91
Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells. J Psychiatr Res (2012) 0.90
Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.90
Identification of schizophrenia-associated loci by combining DNA methylation and gene expression data from whole blood. Eur J Hum Genet (2014) 0.89
A meta-analysis of gene expression quantitative trait loci in brain. Transl Psychiatry (2014) 0.87
Polygenic risk for schizophrenia associated with working memory-related prefrontal brain activation in patients with schizophrenia and healthy controls. Schizophr Bull (2014) 0.86
Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: a meta-analysis. Psychiatry Res (2015) 0.85
Verbal recall and recognition in twins discordant for schizophrenia. Psychiatry Res (2008) 0.85
Proinflammatory cytokines and their membrane-bound receptors are altered in the lymphocytes of schizophrenia patients. Schizophr Res (2015) 0.84
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood. PLoS One (2015) 0.82
Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia. Psychopharmacology (Berl) (2013) 0.81
Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway. JAMA Psychiatry (2014) 0.81
Genetic complexity of episodic memory: a twin approach to studies of aging. Psychol Aging (2014) 0.80
California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res (2014) 0.79
Systematic Integration of Brain eQTL and GWAS Identifies ZNF323 as a Novel Schizophrenia Risk Gene and Suggests Recent Positive Selection Based on Compensatory Advantage on Pulmonary Function. Schizophr Bull (2015) 0.79
Integration of gene expression and GWAS results supports involvement of calcium signaling in Schizophrenia. Schizophr Res (2015) 0.78
Complement Gene Expression Correlates with Superior Frontal Cortical Thickness in Humans. Neuropsychopharmacology (2017) 0.75